Figure 1
VAV2 overexpression induces cytoskeleton remodeling in H295R cells and is a marker of malignancy in ACC. (A) Cytoskeletal
morphology revealed by phalloidin staining (red) in H295R/TR SF-1 cells transfected with vectors encoding either GFP or GFP-VAV2
(green). Scale bars, 5 μm. Reproduced, with permission, from Ruggiero C, Doghman-Bouguerra M, Sbiera S, Sbiera I, Parsons
M, Ragazzon B, Morin A, Robidel R, Favier J & Bertherat J (2017) Dosage-dependent regulation of VAV2 expression by Steroidogenic
actor-1 drives adrenocortical carcinoma cell invasion, Science Signaling, volume 10, eaal2464. Copyright 2017 American Association for the Advancement of Science. (B) OS in ACC patients with both high VAV2
expression (H-score ≥2) and high Ki67 LI (≥20%) group (red line) vs all other patients (green line) P < 0.001, Kaplan–Meier method. Reproduced, with permission, from Sbiera S, Sbiera I, Ruggiero C, Doghman-Bouguerra M, Korpershoek
E, de Krijger RR, Haak H, Volante M, Papotti M, Reimondo G, et al. (2017) Assessment of VAV2 expression refines prognostic prediction in adrenocortical carcinoma, Journal of Clinical Endocrinology and Metabolism, volume 102, pages 3491–3498. Copyright 2017 Oxford University Press.